Elite Pharmaceuticals Inc (ELTP)

[Bngo]

ELTP is way undervalued according to this calculation.

Should be at $0.7959 per share even before all these newly revenue to be reported with the recent launches of Methotrexate, Codeine with Acetaminophen, and generic Adderal in Israel.

There will be significantly more revenue from the launches of generic Percocet around 11/18/24 and generic Norco right after the new year.

Elite will have awesome news soon with another record breaking quarterly earnings press release on 11/14/24 and the approval of generic Vyvanse hopeful in November 2024 ($5.1 billion market).

Casual investors will regret giving up their shares so soon recently.

True long investors with do extremely well with their returns with ELTP when it goes to $5 to $7 within 2 years.


Drug Manufacturers
Specialty & Generic
P/E ratio: 36.96
47 generic companies

ELTP EPS ($0.0191) x Average P/E Ratio by Industry of 47 generic drug manufacturers of (36.96) = Price Per Share ($0.7059)